You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Journal logo
Sections
Ask the Ethicist
At the Bench
Best Advances
Disease Mechanisms
Diversity
For Your Patients
In the Pipeline
Off the Clock
Neurotech
Letters to the Editor
Policy and Practice
Professionalism
The Science Explained
Wellness
Topics
Behavioral Neurology/Dementia
Cerebrovascular Disease
Child Neurology
Epilepsy
Genetics
Headache/Facial Pain
Movement Disorders
Multiple Sclerosis
Neurocritical Care
Neuroinfectious Disease
Neuromuscular
Neuro-oncology
Neuro-ophthalmology/Neuro-otology
Sleep Neurology
Sports Neurology/Concussion
At the Meetings
Meetings We Cover
Most Recent Meeting
About
About Neurology Today
Editorial Board
Subscription Services
Reprints
Rights and Permissions
About the AAN
American Academy of Neurology
Account
Register
Help
American Academy of Neurology
Login
Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy.
Subscribe to eTOC
Home
>
Issue Outline
July 05, 2012
Volume 12, Issue 13
Browse Issues
For Your Patients
For Your Patients
Human Stem Cells Generate Normal Muscle Fibers in Mouse Model of Muscular Dystrophy
For Your Patients
FROM THE AAN & THE CHILD NEUROLOGY SOCIETY: An Updated Review of Infantile Spasms Treatment Options
For Your Patients
NEWS FROM THE AAN ANNUAL MEETING: C9ORF72 Studies Shed Light on the Most Common Genetic Cause of ALS and FTD
For Your Patients
NEWS FROM THE AAN ANNUAL MEETING: Intermediate Repeats in Huntington's Disease: How Significant Are They?
For Your Patients
For Lower Back Pain, Anti-inflammatory Drug Not Found Effective
For Your Patients
NEWS FROM THE AAN ANNUAL MEETING: Alice in Wonderland Syndrome Linked to Migraine, Virus
For Your Patients
Fatty Acids Quell Myelin Inflammation in MS model
For Your Patients
NEWS FROM THE AAN ANNUAL MEETING: Negative Beliefs About Experimental Therapies Trigger Nocebo Effect in Neurology Clinical Trials, New Study Finds
For Your Patients
Levels of Risk Identified for MS Patients Taking Natalizumab
For Your Patients
NEWS FROM THE AAN ANNUAL MEETING: For MS Patients, No Additive Benefit Found in Combining Glatiramer Acetate and Interferon Beta-1A
For Your Patients
NEWS FROM THE AAN ANNUAL MEETING: Which Ischemic Stroke Patients Would Benefit from Reperfusion Therapy? Infarction Size and Age Offer Clues
For Your Patients
NEWS FROM THE AAN ANNUAL MEETING: New Genes Identified for Hereditary Spastic Paraparesis or Charcot-Marie-Tooth
For Your Patients
New Study Predicts Motor Improvement Post-stroke Using MRI-based Assessment
For Your Patients
IN THE FIELD: Sheila Essey Awardee Christopher Shaw, MBChB, MD: On Taking the Back Roads to Unraveling ALS Genetics
For Your Patients
UP & COMING: Kiran Maski, MD: Mending Children's Sleep Habits, Improving Family Relations
Issue Cover
Editor's Pick Podcast
Back to Top